Oxybutynin Tstransdermal Patch Suppliers & Bulk Manufacturers

Available Forms: transdermal patch

Available Strengths: 3.9 mg/24 hours

Reference Brands: Oxytrol, Oxytrol for Women(US & EU)

Category: Multiple sclerosis

Oxybutynin tstransdermal patch is available in transdermal patch and strengths such as 3.9 mg/24 hours. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Oxybutynin tstransdermal patch is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Oxybutynin tstransdermal patch can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Product Description: Oxybutynin transdermal patches, marketed as Oxytrol, are approved in the US by the FDA and in the EU via EMA for managing overactive bladder. Regulatory approval requires a comprehensive dossier including clinical efficacy, safety data, manufacturing quality, and pharmacovigilance plans. In the US, the FDA reviews detailed clinical and quality information, while the EMA ensures compliance with regional safety and manufacturing standards. For guidance on dossier preparation, regulatory pathways, and market access, visit PharmaTradz. Proper regulatory compliance supports timely approval, safe use, and global availability of oxybutynin patches, providing an effective and comfortable option for patients worldwide managing bladder overactivity.